MiR-331-3p Links to Drug Resistance of Pancreatic Cancer Cells by Activating WNT/ β-Catenin Signal via ST7L.

CONCLUSIONS: Taken together, our data demonstrate that miR-331-3p contributes to drug resistance by activating Wnt/β-catenin signaling via ST7L in pancreatic cancer cells. These data provide a theoretical basis for new targeted therapies in the future.
PMID: 32924881 [PubMed - as supplied by publisher]

Source: Technology in Cancer Research and Treatment - December 31, 2019 Category: Cancer & Oncology Authors: Zhan T, Chen X, Tian X, Han Z, Liu M, Zou Y, Huang S, Chen A, Cheng X, Deng J, Tan J, Huang X Tags: Technol Cancer Res Treat Source Type: research